Literature DB >> 9665870

Viral interference with antibody and complement.

J Lubinski1, T Nagashunmugam, H M Friedman.   

Abstract

Viruses have evolved strategies to evade immunity mediated by antibody and complement. Herpesviruses and coronaviruses encode IgG Fc binding proteins that inhibit IgG activity, enabling the virus or infected cell to escape antibody attack. Herpesviruses, vaccinia virus and HIV-1 have the capacity to interfere with complement, either by incorporation of cellular complement regulatory proteins into the virion envelope or cell membrane, or by expression of viral molecules that mimic functions of complement regulatory proteins. The structure and biological activities of herpes simplex virus type 1 (HSV-1) glycoproteins gE, gI and gC are described. These glycoproteins protect HSV from immune attack; HSV-1 gE/gI form a complex that binds the Fc domain of IgG while gC is a C3b binding complement regulatory protein, providing a survival advantage to the virus in vitro and in vivo by inhibiting immune functions. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665870      PMCID: PMC7172161          DOI: 10.1006/scdb.1998.0242

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  34 in total

1.  An N-terminal domain of herpes simplex virus type Ig E is capable of forming stable complexes with gI.

Authors:  S M Rizvi; M Raghavan
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

3.  Serum complement C4a and its relation to liver fibrosis in children with chronic hepatitis C.

Authors:  Behairy E Behairy; Ghada M El-Mashad; Ragab S Abd-Elghany; Enas M Ghoneim; Mostafa M Sira
Journal:  World J Hepatol       Date:  2013-08-27

4.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

5.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Translocation and colocalization of ICP4 and ICP0 in cells infected with herpes simplex virus 1 mutants lacking glycoprotein E, glycoprotein I, or the virion host shutoff product of the UL41 gene.

Authors:  Maria Kalamvoki; Jianguo Qu; Bernard Roizman
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

Review 7.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

Review 8.  Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.

Authors:  Gerlinde R Van de Walle; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.

Authors:  K Ikeda; H Wakimoto; T Ichikawa; S Jhung; F H Hochberg; D N Louis; E A Chiocca
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

10.  Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein.

Authors:  B N Lilley; H L Ploegh; R S Tirabassi
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.